Dr. Michael McNamara has contributed to 3 publications.
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.
McNamara, M. J.,Rybicki, L. A.,Sohal, D.,Allende, D. S.,Videtic, G. M.,Rodriguez, C. P.,Stephans, K. L.,Murthy, S. C.,Raja, S.,Raymond, D.,Ives, D. I.,Bodmann, J. W.,A...; J Gastrointest Oncol. 2016 Apr 02.
See more >>
Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study.
Sohal, D. P.,Shrotriya, S.,Glass, K. T.,Pelley, R. J.,McNamara, M. J.,Estfan, B.,Shapiro, M.,Wey, J.,Chalikonda, S.,Morris-Stiff, G.,Walsh, R. M.,Khorana, A. A.; Cancer. 2015 Feb 14.
See more >>
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.
Mittal, K.,McNamara, M. J.,Curtis, B. R.,McCrae, K. R.; JRSM Open. 2014 Jul 25.
See more >>